Potential Epigenetic Mechanism(s) Associated With the Persistence of Psychoneurological Symptoms in Women Receiving Chemotherapy for Breast Cancer: A Hypothesis

Biological Research for Nursing

Volumn 16, Issue 2, 2014, Pages 160-174

  Lyon, Debra ^a,c   Elmore, Lynne ^b,c   Aboalela, Noran ^b   Merrill Schools, Jacqueline ^b,c   McCain, Nancy ^a   Starkweather, Angela ^a   Elswick Jr , R K ^a,b   Jackson Cook, Colleen ^b,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

cognitive; epigenetic; methylation

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BREAST TUMOR; COGNITIVE; DNA METHYLATION; EPIGENETIC; FEMALE; GENETIC EPIGENESIS; HUMAN; METHYLATION; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT;

COGNITIVE; EPIGENETIC; METHYLATION;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS;

EID: 84894541755     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800413483545     Document Type: Article

References (139)

1. Al-Moghrabi N.,Al-Qasem A. J.,Aboussekhra A.Methylation-related mutations in the BRCA1 promoter in peripheral blood cells from cancer-free women.International Journal of Oncology. 2011;39:129-135.
2. Aristei C.,Stracci F.,Guerrieri P.,Anselmo P.,Armellini R.,Rulli A.,Menghini A. R.Frequency of sister chromatid exchanges and micronuclei monitored over time in patients with early-stage breast cancer: Results of an observational study.Cancer Genetics and Cytogenetics. 2009;192:24-29.
3. Arrowsmith C. H.,Bountra C.,Fish P. V.,Lee K.,Schapira M.Epigenetic protein families: A new frontier for drug discovery.Nature Reviews. Drug Discovery. 2012;11:384-400.
4. Aviv A.,Aviv H.Telomeres, hidden mosaicism, loss of heterozygosity, and complex genetic traits.Human Genetics. 1998;103:2-4.
5. Bachmann I. M.,Halvorsen O. J.,Collett K.,Stefansson I. M.,Straume O.,Haukaas S. A.,Akslen L. A.EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast.Journal of Clinical Oncology. 2006;24:268-273.
6. Badger T.,Segrin C.,Dorros S. M.,Meek P.,Lopez A. M.Depression and anxiety in women with breast cancer and their partners.Nursing Research. 2007;56:44-53.
7. Bartsch H.,Nair J.Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: Role of lipid peroxidation, DNA damage, and repair.Langenbeck's Archives of Surgery. 2006;391:499-510.
8. Berger A. M.,Wielgus K.,Hertzog M.,Fischer P.,Farr L.Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy.Support Care in Cancer. 2010;18:105-114.
9. Biegler K. A.,Anderson A. K. L.,Wenzel L. B.,Osann K.,Nelson E. L.Longitudinal change in telomere length and the chronic stress response in a randomized pilot biobehavioral clinical study: Implications for cancer prevention.Cancer Prevention Research. 2012;10:1173-1182.
10. Bilban-Jakopin C.,Bilban M.Genotoxic effects of radiotherapy and chemotherapy on circulating lymphocytes in patients with Hodgkin's disease.Mutation Research. 2001;497:81-88.
11. Bosveil R.,Durif J.,Guo J.,Mebrek M.,Kwiatkowski F.,Bignon Y. J.,Bernard-Gallon D. J.BRCA2 promoter hypermethylation in sporadic breast cancer.OMICS: A Journal of Integrative Biology. 2012;16:707-710.
12. Bower J. E.,Ganz P. A.,Aziz N.,Fahey J. L.Fatigue and proinflammatory cytokine activity in breast cancer survivors.Psychosomatic Medicine. 2002;64:604-611.
13. Briones T. L.,Woods J.Chemotherapy-induced cognitive impairment is associated with decreases in cell proliferation and histone modifications.BMC Neuroscience. 2011;12:124.
14. Butcher D. T.,Rodenhiser D. I.Epigenetic inactivation of BRCA1 is associated with aberrant expression of CTCF and DNA methyltransferase (DNMT3B) in some sporadic breast tumours.European Journal of Cancer. 2007;43:210-219.
15. Buttiglieri S.,Ruella M.,Risso A.,Spatola T.,Silengo L.,Avvedimento E. V.,Tarella C.The aging effect of chemotherapy on cultured human mesenchymal stem cells.Experimental Hematology. 2011;39:1171-1181.
16. Cardinale F.,Bruzzi P.,Bolognesi C.Role of micronucleus test in predicting breast cancer susceptibility: A systematic review and meta-analysis.British Journal of Cancer. 2012;106:780-790.
17. Carey N.,Marques C. J.,Reik W.DNA demethylases: A new epigenetic frontier in drug discovery.Drug Discovery Today. 2011;16:683-690.
18. Chang C. J.,Yang J. Y.,Xia W.,Chen C. T.,Xie X.,Chao C. H.,.EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-beta-catenin signaling.Cancer Cell. 2011;19:86-100.
19. Cherkas L. F.,Aviv A.,Valdes A. M.,Hunkin J. L.,Gardner J. P.,Surdulescu G. L.,.The effects of social status on biological aging as measured by white-blood-cell telomere length.Aging Cell. 2006;5:361-365.
20. Chia N.,Wang L.,Lu X.,Senut M. C.,Brenner C.,Ruden D. M.Hypothesis: Environmental regulation of 5-hydroxymethylcytosine by oxidative stress.Epigenetics. 2011;6:853-856.
21. Cleeland C. S.,Bennett G. J.,Dantzer R.,Dougherty P. M.,Dunn A. J.,Meyers C. A.,Lee B. N.Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms.Cancer. 2003;97:2919-2925.
22. Collado-Hidalgo A.,Bower J. E.,Ganz P. A.,Irwin M. R.,Cole S. W.Cytokine gene polymorphisms and fatigue in breast cancer survivors: Early findings.Brain, Behavior, and Immunity. 2008;22:1197-1200.
23. Collett K.,Eide G. E.,Arnes J.,Stefansson I. M.,Eide J.,Braaten A.,.Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer.Clinical Cancer Research. 2006;12:1168-1174.
24. Coussens L. M.,Werb Z.Inflammation and cancer.Nature. 2002;420:860-867.
25. Damjanovic A. K.,Yang Y.,Glaser R.,Kiecolt-Glaser J. K.,Nguyen H.,Laskowski B.,.Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer's disease patients.Journal of Immunology. 2007;179:4249-4254.
26. Dantzer R.,O'Connor J. C.,Freund G. G.,Johnson R. W.,Kelley K. W.From inflammation to sickness and depression: When the immune system subjugates the brain.Nature Reviews. Neuroscience. 2008;9:46-56.
27. Day J. J.,Sweatt J. D.Cognitive neuroepigenetics: A role for epigenetic mechanisms in learning and memory.Neurobiology of Learning and Memory. 2011;96:2-12.
28. De Vivo I.,Prescott J.,Wong J. Y.,Kraft P.,Hankinson S. E.,Hunter D. J.A prospective study of relative telomere length and postmenopausal breast cancer risk.Cancer Epidemiology Biomarkers & Prevention. 2009;18:1152-1156.
29. Dedert E.,Lush E.,Chagpar A.,Dhabhar F. S.,Segerstrom S. C.,Spiegel D.,.Stress, coping, and circadian disruption among women awaiting breast cancer surgery.Annals of Behavioral Medicine. 2012;44:10-20.
30. Dedeurwaerder S.,Desmedt C.,Calonne E.,Singhal S.,Haibe-Kains B.,Defrance M.,.DNA methylation profiling reveals a predominant immune component in breast cancers.EMBO Molecular Medicine. 2011;3:726-741.
31. Diehl M. C.,Idowu M. O.,Kimmelshue K. N.,York T. P.,Jackson-Cook C. K.,Turner K. C.,.Elevated TRF2 in advanced breast cancers with short telomeres.Breast Cancer Research and Treatment. 2011;127:623-630.
32. Ding L.,Erdmann C.,Chinnaiyan A. M.,Merajver S. D.,Kleer C. G.Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues.Cancer Research. 2006;66:4095-4099.
33. Dodd M. J.,Cho M. H.,Cooper B. A.,Miaskowski C.The effect of symptom clusters on functional status and quality of life in women with breast cancer.European Journal of Oncology Nursing. 2010;14:101-110.
34. Effros R. B.Telomere/telomerase dynamics within the human immune system: Effect of chronic infection and stress.Experimental Gerontology. 2011;46:135-140.
35. Elsendoorn T. J.,Weijl N. I.,Mithoe S.,Zwinderman A. H.,van Dam F.,De Zwart F. A.,.Chemotherapy-induced chromosomal damage in peripheral blood lymphocytes of cancer patients supplemented with antioxidants or placebo.Mutation Research. 2001;498:145-158.
36. Epel E. S.Psychological and metabolic stress: A recipe for accelerated cellular aging?.Hormones. 2009;8:7-22.
37. Epel E. S.,Blackburn E.,Lin J.,Dhabhar F. S.,Adler N. E.,Morrow J. D.,Cawthon R. M.Accelerated telomere shortening in response to exposure to life stress.Proceedings on the National Academy of Sciences. 2004;101:7312-17315.
38. Esteller M.Aberrant DNA methylation as a cancer-inducing mechanism.Annual Review of Pharmacology and Toxicology. 2005;45:629-656.
39. Esteller M.Epigenetics in cancer.New England Journal of Medicine. 2008;358:1148-1159.
40. Faggioli F.,Vijg J.,Montagna C.Chromosomal aneuploidy in the aging brain.Mechanisms of Ageing and Development. 2011;132:429-436.
41. Fang F.,Turcan S.,Rimner A.,Kaufman A.,Giri D.,Morris L. G. T.Breast cancer methylomes establish an epigenomic foundation for metastasis.Science Translational Medicine. 2011;3:75ra25.
42. Feinberg A. P.,Irizarry R. A.,Fradin D.,Aryee M. J.,Murakami P.,Aspelund T.,.Personalized epigenomic signatures that are stable over time and covary with body mass index.Science Translational Medicine. 2010;2:49-67.
43. Fitzpatrick D. A.,Kronmal R. A.,Gardner J. P.,Psaty B. M.,Jenny N. S.,Tracy R. P.,.Leukocyte telomere length and cardiovascular disease in the cardiovascular health study.American Journal of Epidemiology. 2007;165:14-21.
44. Flanary B. E.,Streit W. J.Progressive telomere shortening occurs in cultured rat microglia, but not astrocytes.Glia. 2004;45:75-88.
45. Goedendorp M. M.,Gielissen M. F.,Verhagen C. A.,Peters M. E.,Bleijenberg G.Severe fatigue and related factors in cancer patients before the initiation of treatment.British Journal of Cancer. 2008;99:1408-1414.
46. Goel S.,Bhatia A.,Dey P.Spontaneously occurring micronuclei in infiltrating ductal carcinoma of breast: A potential biomarker for aggressive phenotype detection?.Diagnostic Cytopathology. 2011;:1-7.
47. Gong Y.,Huo L.,Liu P.,Sneige N.,Sun X.,Ueno N. T.,.Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome.Cancer. 2011;117:5476-5484.
48. Gonzalez M. E.,Li X.,Toy K.,DuPrie M.,Ventura A. C.,Banerjee M.,.Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1.Oncogene. 2009;28:843-853.
49. Gramatges M. M.,Telli M. L.,Balise R.,Ford J. M.Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controls.Cancer Epidemiology Biomarkers & Prevention. 2010;19:605-613.
50. Greer E. L.,Shi Y.Histone methylation: A dynamic mark in health, disease and inheritance.Nature Reviews Genetics. 2012;13:343-357.
51. Grzenda A.,Ordog T.,Urrutia R.Polycomb and the emerging epigenetics of pancreatic cancer.Journal of Gastrointestinal Cancer. 2011;42:100-111.
52. Gupta R.,Nagarajan A.,Wajapeyee N.Advances in genome-wide DNA methylation analysis.BioTechniques. 2010;49:iii-xi.
53. Hansen J. A.,Feuerstein M.,Calvio L. C.,Olsen C. H.Breast cancer survivors at work.Journal of Occupational and Environmental Medicine. 2008;50:777-784.
54. Hewitt G.,Jurk D.,Marques F. D. M.,Correia-Melo C.,Hardy T.,Gackowska A.,.Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence.Nature Communications. 2012;3:708.
55. Huang Y.,Nayak S.,Jankowitz R.,Davidson N.,Oesterreich S.Epigenetics in breast cancer: What's new?.Breast Cancer Research. 2011;13:225.
56. Humphreys K.,Epel E. S.,Cooper B. A.,Lin J.,Blackburn E. H.,Lee K. A.Telomere shortening in formerly abused and never abused women.Biological Research for Nursing. 2012;14:115-123.
57. Iourov I. Y.,Vorsanova S. G.,Yurov Y. B.Chromosomal mosaicism goes global.Molecular Cytogenetics. 2008a;1:26.
58. Iourov I. Y.,Vorsanova S. G.,Yurov Y. B.Molecular cytogenetics and cytogenomics of brain diseases.Current Genomics. 2008b;9:452-465.
59. Issa J. P. J.,Shen L.,Toyota M.CIMP, at last.Gastroenterology. 2005;129:1121-1124.
60. Iwamoto T.,Yamamoto N.,Taguchi T.,Tamaki Y.,Noguchi S.BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation.Breast Cancer Research and Treatment. 2011;129:69-77.
61. Jackson-Cook C.Constitutional and acquired autosomal aneuploidy.Clinics in Laboratory Medicine. 2011;31:481-511.
62. Jacobs D. I.,Hansen J.,Fu A.,Stevens R. G.,Tjonneland A.,Vogel U. B.,.Methylation alterations at imprinted genes detected among long-term shiftworkers.Environmental and Molecular Mutagenesis. 2013;54:141-146.
63. Janssen A.,Medema R. H.Genetic instability: Tipping the balance.Oncogene. 2012;:1-12.
64. Jin S. G.,Wu X.,Li A. X.,Pfeifer G. P.Genomic mapping of 5-hydroxymethylcytosine in the human brain.Nucleic Acids Research. 2011;39:5015-5024.
65. Jones P. A.,Liang G.Rethinking how DNA methylation patterns are maintained.Nature Reviews Genetics. 2009;10:805-811.
66. Jovanovic J.,Rønneberg J. A.,Tost J.,Kristensen V.The epigenetics of breast cancer.Molecular Oncology. 2010;4:242-254.
67. Kelley K. W.,Bluthe R. M.,Dantzer R.,Zhou J. H.,Shen W. H.,Johnson R. W.,Broussard S. R.Cytokine-induced sickness behavior.Brain, Behavior, and Immunity. 2003;17:S112-118.
68. Kim S.,Bi X.,Czarny-Ratajczak M.,Dai J.,Welsh D. A.,Myers L.,.Telomere maintenance genes SIRT1 and XRCC6 impact age-related decline in telomere length but only SIRT1 is associated with human longevity.Biogerontology. 2011;13:119-131.
69. Kingsbury M. A.,Friedman B.,McConnell M. J.,Rehen S. K.,Yang A. H.,Kaushal D.,Chun J.Aneuploid neurons are functionally active and integrated into brain circuitry.Proceedings of the National Academy of Sciences of the United States of America. 2005;102:6143-6147.
70. Kirsch-Volders M.,Plas G.,Elhajouji A.,Lukamowicz M.,Gonzalez L.,Vande Loock K.,Decordier I.The in vitro MN assay in 2011: Origin and fate, biological significance, protocols, high throughput methodologies and toxicological relevance.Archives of Toxicology. 2011;85:873-899.
71. Kleer C. G.,Cao Q.,Varambally S.,Shen R.,Ota I.,Tomlins S. A.,.EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells.Proceedings of the National Academy of Sciences. 2003;100:11606-11611.
72. Kouzarides T.Chromatin modifications and their function.Cell. 2007;128:693-705.
73. Kriaucionis S.,Heintz N.The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain.Science. 2009;324:929-930.
74. Kume K.,Kikukawa M.,Hanyu H.,Takata Y.,Umahara T.,Sakurai H.,.Telomere length shortening in patients with dementia with Lewy bodies.European Journal of Neurology. 2012;19:905-910.
75. Lee K.,Cho M.,Miaskowski C.,Dodd M.Impaired sleep and rhythms in persons with cancer.Sleep Medicine Reviews. 2004;8:199-212.
76. Lubin F. D.,Gupta S.,Parrish R. R.,Grissom N. M.,Davis R. L.Epigenetic mechanisms: Critical contributors to long-term memory formation.Neuroscientist. 2011;17:616-632.
77. Mantovani A.,Allavena P.,Sica A.,Balkwill F.Cancer-related inflammation.Nature. 2008;454:436-444.
78. Martin-Ruiz C.,Dickinson H. O.,Keys B.,Rowan E.,Kenny R. A.,Von Zglinicki T.Telomere length predicts poststroke mortality, dementia, and cognitive decline.Annals of Neurology. 2006;60:174-180.
79. Mathews H. L.,Konley T.,Kosik K. L.,Krukowski K.,Eddy J.,Albuquerque K.,Janusek L. W.Epigenetic patterns associated with the immune dysregulation that accompanies psychosocial distress.Brain, Behavior, and Immunity. 2011;25:830-839.
80. Mazzio E. A.,Soliman K. F.Basic concepts of epigenetics: Impact of environmental signals on gene expression.Epigenetics. 2012;7:119-130.
81. McCormick V. A.,Silva I. D. S.Breast density and parenchymal patterns as markers of breast cancer risk: A meta-analysis.Cancer Epidemiology Biomarkers & Prevention. 2006;15:1159-1169.
82. Meeker A. K.,Argani P.Telomere shortening occurs early during breast tumorigenesis: A cause of chromosome destabilization underlying malignant transformation?.Journal of Mammary Gland Biological Neoplasia. 2004;9:285-296.
83. Mehler M. F.Epigenetic principles and mechanisms underlying nervous system functions in health and disease.Progress in Neurobiology. 2008;86:305-341.
84. Mehnert A.Employment and work-related issues in cancer survivors.Critical Reviews in Oncology/Hematology. 2011;77:109-130.
85. Miller G. E.,Chen E.,Parker K. J.Psychological stress in childhood and susceptibility to the chronic diseases of aging: Moving toward a model of behavioral and biological mechanisms.Psychological Bulletin. 2011;137:959-997.
86. Miloševic-Djordjevic O.,Grujicic D.,Vaskovic Z.,Marinkovic D.High micronucleus frequency in peripheral blood lymphocytes of untreated cancer patients irrespective of gender, smoking and cancer sites.Tohoku Journal of Experimental Medicine. 2010;220:115-120.
87. Miranda T. B.,Jones P. A.DNA methylation: The nuts and bolts of repression.Journal of Cellular Physiology. 2007;213:384-390.
88. Mohammed S. I.,Springfield S.,Das R.Role of epigenetics in cancer health disparities.Methods in Molecular Biology. 2012;863:395-410.
89. Muotri A.,Gage F.Generation of neuronal variability and complexity.Nature. 2006;441:1087-1093.
90. O'Donovan A.,Pantell M. S.,Puterman E.,Dhabhar F. S.,Blackburn E. H.,Yaffe K.,.Cumulative inflammatory load is associated with short leukocyte telomere length in the Health, Aging and Body Composition Study.PloS One. 2011;6:e19687.
91. O'Donovan A.,Tomiyama A. J.,Lin J.,Puterman E.,Adler N. E.,Kemeny M.,.Stress appraisals and cellular aging: A key role for anticipatory threat in the relationship between psychological stress and telomere length.Brain, Behavior, and Immunity. 2012;26:573-579.
92. O'Sullivan R. J.,Karlseder J.Telomeres: Protecting chromosomes against genome instability.Nature Reviews Molecular Cell Biology. 2010;11:171-181.
93. Pampalona J.,Soler D.,Genescà A.,Tusell L.Whole chromosome loss is promoted by telomere dysfunction in primary cells.Genes, Chromosomes and Cancer. 2010;49:368-378.
94. Parks C. G.,Miller D. B.,McCanlies E. C.,Cawthon R. M.,Andrew M. E.,DeRoo L. A.,Sandler D. P.Telomere length, current perceived stress, and urinary stress hormones in women.Cancer Epidemiology Biomarkers & Prevention. 2009;18:551-560.
95. Parrella P.Epigenetic signatures in breast cancer: Clinical perspective.Breast Care. 2010;5:66-73.
96. Peres J.Telomere research offers insight on stress-disease link.Journal of The National Cancer Institute. 2011;103:848-850.
97. Pooley K. A.,Sandhu M. S.,Tyrer J.,Shah M.,Driver K. E.,Luben R. N.,.Telomere length in prospective and retrospective cancer case-control studies.Cancer Research. 2010;70:3170-3176.
98. Ptak C.,Petronis A.Epigenetics and complex disease: From etiology to new therapeutics.Annual Review of Pharmacology and Toxicology. 2008;48:257-276.
99. Puterman E.,Lin J.,Blackburn E.,O'Donovan A.,Adler N.,Epel E.The power of exercise: Buffering the effect of chronic stress on telomere length.PLoS One. 2010;5:e10837.
100. Quivy V.,Calomme C.,Dekoninck A.,Demonte D.,Bex F.,Lamsoul I.,.Gene activation and gene silencing: A subtle equilibrium.Cloning and Stem Cells. 2004;6:140-149.
101. Raaphorst F. M.,Meijer C. J.,Fieret E.,Blokzijl T.,Mommers E.,Buerger H.,.Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene.Neoplasia. 2003;5:481-488.
102. Raison C. L.,Capuron L.,Miller A. H.Cytokines sing the blues: Inflammation and the pathogenesis of depression.Trends in Immunology. 2006;27:24-31.
103. Roberts R. O.,Geda Y. E.,Knopman D. S.,Cha R. H.,Boeve B. F.,Ivnik R. J.,.Metabolic syndrome, inflammation, and nonamnestic mild cognitive impairment in older persons: A population-based study.Alzheimer Disease and Associated Disorders. 2010;24:11-18.
104. Rush M.,Appanah R.,Lee S.,Lam L. L.,Goyal P.,Lorincz M. C.Targeting of EZH2 to a defined genomic site is sufficient for recruitment of Dnmt3a but not de novo DNA methylation.Epigenetics. 2009;4:404-414.
105. Samanta S.,Dey P.,Nijhawan R.The role of micronucleus scoring in fine needle aspirates of ductal carcinoma of the breast.Cytopathology. 2011;22:111-114.
106. Santos F.,Hyslop L.,Stojkovic P.,Leary C.,Murdoch A.,Reik W.,.Evaluation of epigenetic marks in human embryos derived from IVF and ICSI.Human Reproduction. 2010;25:2387-2395.
107. Schlesinger Y.,Straussman R.,Keshet I.,Farkash S.,Hecht M.,Zimmerman J.,.Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer.Nature Genetics. 2006;39:232-236.
108. Schmidt R. J.,Hansen R. L.,Hartiala J.,Allayee H.,Schmidt L. C.,Tancredi D. J.,.Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism.Epidemiology. 2011;22:476-485.
109. Schroeder C. P.,Wisman G. B.,de Jong S.,van der Graaf W. T.,Ruiters M. H.,Mulder N. H.,de Vries E. G.Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation.British Journal of Cancer. 2001;18:1348-1353.
110. Sephton S.,Spiegel D.Circadian disruption in cancer: A neuroendocrine-immune pathway from stress to disease?.Brain, Behavior, and Immunity. 2003;17:321-328.
111. Serrano A. L.,Andrés V.Telomeres and cardiovascular disease: Does size matter?.Circulation Research. 2004;94:575-584.
112. Shen J.,Terry M. B.,Gurvich I.,Liao Y.,Senie R. T.,Santella R. M.Short telomere length and breast cancer risk: A study in sister sets.Cancer Research. 2007;67:5538-5544.
113. Sibille K. T.,Langaee T.,Burkley B.,Gong Y.,Glover T. L.,King C.,.Chronic pain, perceived stress, and cellular aging: An exploratory study.Molecular Pain. 2012;8:12.
114. Siegel R.,Naishadham D.,Jemal A.Cancer statistics, 2012.CA: A Cancer Journal for Clinicians. 2012;62:10-29.
115. Simon J. A.,Lange C. A.Roles of the EZH2 histone methyltransferase in cancer epigenetics.Mutation Research. 2008;647:21-29.
116. Simon N. M.,Smoller J. W.,McNamara K. L.,Maser R. S.,Zalta A. K.,Pollack M. H.,.Telomere shortening and mood disorders: Preliminary support for a chronic stress model of accelerated aging.Biological Psychiatry. 2006;60:432-435.
117. Stefansson O. A.,Esteller M.EZH2-mediated epigenetic repression of DNA repair in promoting breast tumor initiating cells.Breast Cancer Research. 2011;13:309.
118. Strub G. M.,Depcrynski A.,Elmore L. W.,Holt S. E.Recovery from stress is a function of age and telomere length.Cell Stress and Chaperones. 2008;13:475-482.
119. Tahiliani M.,Koh K. P.,Shen Y.,Pastor W. A.,Bandukwala H.,Brudno Y.Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1.Science. 2009;324:930-935.
120. Terry M. B.,Delgado-Cruzata L.,Vin-Raviv N.,Wu H. C.,Santella R. M.DNA methylation in white blood cells: Association with risk factors in epidemiologic studies.Epigenetics. 2011;6:828-837.
121. Toyokawa S.,Uddin M.,Koenen K. C.,Galea S.How does the social environment 'get into the mind'? Epigenetics at the intersection of social and psychiatric epidemiology.Social Science and Medicine. 2012;74:67-74.
122. Tsang D. P.,Cheng A. S.Epigenetic regulation of signaling pathways in cancer: Role of the histone methyltransferase EZH2.Journal of Gastroenterology and Hepatology. 2011;26:19-27.
123. Utne I.,Miaskowski C.,Bjordal K.,Paul S. M.,Rustoen T.The relationships between mood disturbances and pain, hope, and quality of life in hospitalized cancer patients with pain on regularly scheduled opioid analgesic.Journal of Palliative Medicine. 2010;13:311-318.
124. Valdes A. M.,Deary I. J.,Gardner J.,Kimura M.,Lu X.,Spector T. D.,.Leukocyte telomere length is associated with cognitive performance in healthy women.Neurobiological Aging. 2010;31:986-992.
125. Valeberg B. T.,Rustoen T.,Bjordal K.,Hanestad B. R.,Paul S.,Miaskowski C.Self-reported prevalence, etiology, and characteristics of pain in oncology outpatients.European Journal of Pain. 2008;12:582-590.
126. Vardy J.,Wefel J. S.,Ahles T.,Tannock I. F.,Schagen S. B.Cancer and cancer-therapy related cognitive dysfunction: An international perspective from the Venice cognitive workshop.Annals of Oncology. 2008;19:623-629.
127. Varga D.,Hoegel J.,Maier C.,Jainta S.,Hoehne M.,Patino-Garcia B.,.On the difference of micronucleus frequencies in peripheral blood lymphocytes between breast cancer patients and controls.Mutagenesis. 2006;21:313-320.
128. Veeck J.,Esteller M.Breast cancer epigenetics: From DNA methylation to microRNAs.Journal of Mammary Gland Biology and Neoplasia. 2010;15:5-17.
129. Viré E.,Brenner C.,Deplus R.,Blanchon L.,Fraga M.,Didelot C.,.The Polycomb group protein EZH2 directly controls DNA methylation.Nature. 2006;439:871-874.
130. Walker S. L.,Ariga J.,Mathias J. R.,Coothankandaswamy V.,Xie X.,Distel M.,.Automated reporter quantification in vivo: High-throughput screening method for reporter-based assays in zebrafish.PLoS One. 2012;7:e29916.
131. Wang X.,Wu X.,Liang Z.,Huang Y.,Fenech M.,Xue J.A comparison of folic acid deficiency-induced genomic instability in lymphocytes of breast cancer patients and normal non-cancer controls from a Chinese population in Yunnan.Mutagenesis. 2006;21:41-47.
132. Wefel J. S.,Vardy J.,Ahles T.,Shagan S.International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer.The Lancet Oncology. 2011;12:703-708.
133. Wikgren M.,Maripuu M.,Karlsson T.,Nordfjäll K.,Bergdahl J.,Hultdin J.,.Short telomeres in depression and the general population are associated with a hypocortisolemic state.Biological Psychiatry. 2012;71:294-300.
134. Wilson A. S.,Power B. E.,Molloy P. L.DNA hypomethylation and human diseases.Biochimica et Biophysica Acta-Reviews on Cancer. 2007;1775:138-162.
135. Wojda A.,Witt M.Manifestations of ageing at the cytogenetic level.Journal of Applied Genetics. 2003;44:383-400.
136. Yaffe K.,Lindquist K.,Kluse M.,Cawthon R.,Harris T.,Hsueh W.-C.,.Telomere length and cognitive function in community-dwelling elders: Findings from the Health ABC Study.Neurobiology of Aging. 2011;32:2055-2060.
137. Yurov Y. B.,Iourov I. Y.,Vorsanova S. G.,Demidova I. A.,Kravetz V. S.,Beresheva A. K.,.The schizophrenia brain exhibits low-level aneuploidy involving chromosome 1.Schizophrenia Research. 2008;98:139-147.
138. Zeng Y.,Tan M.,Kohyama J.,Sneddon M.,Watson J. B.,Sun Y. E.,Xie C. W.Epigenetic enhancement of BDNF signaling rescues synaptic plasticity in aging.Journal of Neuroscience. 2011;31:17800-17810.
139. Zheng Y.-L.,Ambrosone C.,Byrne C.,Davis W.,Nesline M.,McCann S.Telomere length in blood cells and breast cancer risk: Investigations in two case-control studies.Breast Cancer Research and Treatment. 2010;120:769-775.